CSS LLC/IL - ISIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
CSS LLC/IL ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$724,000
+42.8%
17,900
+103.4%
0.04%
+79.2%
Q2 2015$507,000
-70.1%
8,800
-66.9%
0.02%
-72.1%
Q1 2015$1,695,000
-46.1%
26,624
-47.7%
0.09%
-44.9%
Q4 2014$3,142,000
+59.0%
50,9000.0%0.16%
+62.5%
Q3 2014$1,976,000
-5.8%
50,900
-16.4%
0.10%
+10.3%
Q2 2014$2,097,000
+35.2%
60,900
+69.6%
0.09%
+11.5%
Q1 2014$1,551,00035,9000.08%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 6,417,548$255,675,00013.66%
HWG Holdings LP 339,799$13,538,0008.73%
DOWLING & YAHNKE LLC 675,798$26,924,0003.78%
GARRISON BRADFORD & ASSOCIATES INC 99,300$3,956,0003.74%
WILLIAM HARRIS INVESTORS INC 283,834$11,308,0003.35%
SECTORAL ASSET MANAGEMENT INC 1,222,401$48,700,0002.10%
AVALON CAPITAL MANAGEMENT 49,999$1,992,0001.68%
PINNACLE ASSOCIATES LTD 2,016,369$80,332,0001.57%
PERKINS CAPITAL MANAGEMENT INC 48,515$1,933,0001.30%
NCM Capital Advisers, Inc. 31,100$1,239,0001.28%
View complete list of ISIS PHARMACEUTICALS INC shareholders